BNP Paribas Financial Markets
OMGA

BNP Paribas Financial Markets’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

BNP Paribas Financial Markets’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-235
Closed -$175 – 5639
2024
Q4 		$175 Buy
+235
New +$234 ﹤0.01% 5243

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BNP Paribas Financial Markets's OMGA Position: Q1 2025 in Review

BNP Paribas Financial Markets sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 235 shares — an estimated $175 sold.

BNP Paribas Financial Markets first reported a position in OMGA in Q4 2024 and held it in 1 quarter. The position peaked at $175 in Q4 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • BNP Paribas Financial Markets reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 235 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $175.
  • BNP Paribas Financial Markets first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Omega Therapeutics, Inc. Common Stock position peaked at $175 in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.